Retatrutide (LY3437943) Peptide Powder – High Purity Lyophilized Research Peptide

Product Overview

Retatrutide (LY3437943) is a next-generation synthetic peptide engineered as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Its innovative molecular design distinguishes it from earlier single- and dual-receptor peptide technologies, making it one of the most widely studied compounds in contemporary metabolic research.

Supplied as a high-purity lyophilized powder, Retatrutide offers excellent stability for laboratory handling, transportation, and long-term storage. It is commonly utilized in scientific investigations involving receptor signaling, metabolic regulation, peptide engineering, and endocrine research.

Key Features

✔ High Purity (≥98% HPLC)

✔ White to Off-White Lyophilized Powder

✔ Excellent Stability for Research Applications

✔ Triple Receptor Agonist Technology

✔ Strict Quality Control and Batch Consistency

✔ Suitable for Advanced Peptide Research

Product Specifications

*Specifications may vary according to manufacturing batch and analytical standards.

Mechanism of Action

Retatrutide is designed to simultaneously activate three metabolic hormone receptors:

GLP-1 Receptor

Associated with appetite regulation, gastric emptying pathways, and glucose-related signaling mechanisms.

GIP Receptor

Involved in nutrient sensing, insulin signaling, and metabolic regulation processes.

Glucagon Receptor

Linked to energy expenditure, lipid metabolism, and metabolic adaptation pathways.

The combined activation of these three receptor systems makes Retatrutide a unique research compound for investigating complex metabolic interactions and multi-pathway biological responses.

Research Applications

Retatrutide has become an important subject in several areas of scientific research, including:

• Metabolic pathway studies
• Peptide receptor signaling research
• Endocrine system investigations
• Energy homeostasis research
• Obesity and metabolic disorder research models
• Structure-activity relationship studies
• Advanced peptide engineering projects

Researchers continue to explore its unique triple-agonist profile and its potential implications for future peptide development.

Quality Assurance

Every batch of Retatrutide should undergo rigorous analytical testing, including:

• High-Performance Liquid Chromatography (HPLC)
• Mass Spectrometry (MS)
• Appearance Verification
• Purity Assessment
• Batch Consistency Evaluation

A Certificate of Analysis (COA) can be provided upon request to ensure product quality and traceability.

Storage & Handling

To maintain optimal peptide stability:

Long-Term Storage

• Store at -20°C or below
• Protect from direct light exposure
• Keep container tightly sealed

After Reconstitution

• Follow laboratory handling procedures
• Minimize repeated freeze-thaw cycles
• Use appropriate sterile research-grade diluents

Proper storage conditions help preserve peptide integrity and analytical performance.

Packaging Options

Available packaging options may include:

• 2mg/Vial
• 5mg/Vial
• 10mg/Vial
• 15mg/Vial
• Custom Packaging Available

Bulk quantities and OEM packaging services are available for qualified research organizations.

Disclaimer

Retatrutide is supplied strictly for laboratory research and analytical purposes only. This product is not approved for human consumption, medical use, therapeutic application, or diagnostic procedures. Researchers are responsible for ensuring compliance with all applicable regulations and institutional guidelines.